APA (7th ed.) Citation

YT, T., J, L., & SH, L. (2026). Refractory Lichen Amyloidosis Coexisting With Atopic Dermatitis Responsive to Sequential Janus Kinase Inhibitor Therapy: Upadacitinib Followed by Abrocitinib. The Kaohsiung journal of medical sciences, 42(4), e70146. https://doi.org/10.1002/kjm2.70146

Chicago Style (17th ed.) Citation

YT, Tsai, Lan J, and Lin SH. "Refractory Lichen Amyloidosis Coexisting With Atopic Dermatitis Responsive to Sequential Janus Kinase Inhibitor Therapy: Upadacitinib Followed by Abrocitinib." The Kaohsiung Journal of Medical Sciences 42, no. 4 (2026): e70146. https://doi.org/10.1002/kjm2.70146.

MLA (9th ed.) Citation

YT, Tsai, et al. "Refractory Lichen Amyloidosis Coexisting With Atopic Dermatitis Responsive to Sequential Janus Kinase Inhibitor Therapy: Upadacitinib Followed by Abrocitinib." The Kaohsiung Journal of Medical Sciences, vol. 42, no. 4, 2026, p. e70146, https://doi.org/10.1002/kjm2.70146.